1-3 of 3
Sona Pekova, M.D., PhD.
Close
Sort by
Journal Articles

Molecular Variability of FLT3/ITD Mutants and Their Impact on the Differentiation Program of 32D Cells: Implications for the Biological Properties of AML Blasts

Sona Pekova, M.D., PhD., Michal Dvorak, PhD., Robert Ivanek, Sabrina Rueggeberg, Stefan Leicht, Tomas Kozak, MD, PhD, Jiri Vrba, MD., Jiri Schwarz, MD., PHD., Petr Cetkovsky, MD., PHD., Miroslav Prucha, MD., PHD., Ondrej Hrusak
Journal: Blood
Blood (2008) 112 (11): 4480.
https://doi.org/10.1182/blood.V112.11.4480.4480
Published: 2008
Journal Articles

Circulating Angiogenic Cytokines in Chronic Lymphocytic Leukemia: Relationship to Modern Prognostic Factors and Effect of Fludarabine-Based Treatment

Lukas Smolej, MD, PhD, Ctirad Andrys, M.S., Ph.D., Sona Pekova, M.D., PhD., Lenka Kucerova, M.S., Monika Hrudkova, M.D., David Belada, M.D., Ph.D., Jaroslav Maly, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 4186.
https://doi.org/10.1182/blood.V112.11.4186.4186
Published: 2008
Journal Articles

Delta Ex6, the Novel Transactivation-Defective Splicing Variant of p53 Gene, Is Differentially Expressed in Patients with Chronic Lymphocytic Leukemia and Confers Accented Proliferative Phenotype in Vitro

Sona Pekova, M.D., PhD., Radek Cmejla, PhD, Tomas Kozak, MD, PhD, Lukas Smolej, MD, PhD, Martin Spacek, MD., Miroslav Prucha, MD., PhD., Ondrej Hrusak
Journal: Blood
Blood (2008) 112 (11): 3795.
https://doi.org/10.1182/blood.V112.11.3795.3795
Published: 2008